Nature Communications (Dec 2023)

Activation of ILC2s through constitutive IFNγ signaling reduction leads to spontaneous pulmonary fibrosis

  • Natsuko Otaki,
  • Yasutaka Motomura,
  • Tommy Terooatea,
  • S. Thomas Kelly,
  • Miho Mochizuki,
  • Natsuki Takeno,
  • Shigeo Koyasu,
  • Miu Tamamitsu,
  • Fuminori Sugihara,
  • Junichi Kikuta,
  • Hideya Kitamura,
  • Yoshiki Shiraishi,
  • Jun Miyanohara,
  • Yuji Nagano,
  • Yuji Saita,
  • Takashi Ogura,
  • Koichiro Asano,
  • Aki Minoda,
  • Kazuyo Moro

DOI
https://doi.org/10.1038/s41467-023-43336-6
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 20

Abstract

Read online

Abstract Pulmonary fibrosis (PF), a condition characterized by inflammation and collagen deposition in the alveolar interstitium, causes dyspnea and fatal outcomes. Although the bleomycin-induced PF mouse model has improved our understanding of exogenous factor-induced fibrosis, the mechanism governing endogenous factor-induced fibrosis remains unknown. Here, we find that Ifngr1 -/- Rag2 -/- mice, which lack the critical suppression factor for group 2 innate lymphoid cells (ILC2), develop PF spontaneously. The onset phase of fibrosis includes ILC2 subpopulations with a high Il1rl1 (IL-33 receptor) expression, and fibrosis does not develop in ILC-deficient or IL-33-deficient mice. Although ILC2s are normally localized near bronchioles and blood vessels, ILC2s are increased in fibrotic areas along with IL-33 positive fibroblasts during fibrosis. Co-culture analysis shows that activated-ILC2s directly induce collagen production from fibroblasts. Furthermore, increased IL1RL1 and decreased IFNGR1 expressions are confirmed in ILC2s from individuals with idiopathic PF, highlighting the applicability of Ifngr1 -/- Rag2 -/- mice as a mouse model for fibrosis research.